Aignostics is an AI-powered precision diagnostics focused on pathology to assist with drug development and clinical research.
Aignostics has raised $34.0M in total funding. The most recent round was Series B. The last funding was announced in October 2024.
Aignostics's investors include HTGF (High-Tech Gruenderfonds), Wellington Partners, IBB Ventures, Mayo Clinic, Boehringer Ingelheim Venture Fund.
Aignostics is headquartered in Berlin, Germany.
Aignostics is an AI-powered precision diagnostics focused on pathology to assist with drug development and clinical research.
Aignostics is at the Series B stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Aignostics — Funding & Investors." VCBacked, October 29, 2024, https://www.vcbacked.co/company/aignostics. Accessed July 19, 2026.
VCBacked. (2024). Aignostics — Funding & Investors. Retrieved July 19, 2026, from https://www.vcbacked.co/company/aignostics
{{cite web |title=Aignostics — Funding & Investors |url=https://www.vcbacked.co/company/aignostics |website=VCBacked |access-date=July 19, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated